Patient-centricity is increasingly at the heart of UK pharma and healthcare research. Quantitative methods allow experienced researchers to capture patient experiences, preferences, and outcomes, informing clinical strategies, market access, and commercial decision-making. Measuring Patient Preferences Discrete choice experiments (DCEs), conjoint analysis, and rating scales help quantify how patients value treatment attributes such […]
Category Archives: SHOW ALL BLOG ARTICLES
Digital Transformation in UK Quantitative Market Research
The UK pharma and healthcare sector is undergoing rapid digital transformation, and quantitative research is no exception. Emerging technologies, automation, and data-driven platforms are reshaping how researchers collect, analyse, and communicate insights. Automation in Data Collection and Analysis Digital platforms enable automated survey distribution, data cleaning, and preliminary analysis. This reduces manual effort […]
HEOR and Market Access: The Quant Researcher’s Role in the UK
Health Economics and Outcomes Research (HEOR) is central to demonstrating the value of therapies in the UK pharmaceutical market. Quantitative researchers play a pivotal role in generating the data and insights that underpin reimbursement, pricing, and market access decisions, particularly in the context of NICE and NHS evaluation. Understanding the UK Market Context […]
The Integration of RWD in UK Quantitative Market Research
Real-world data (RWD) is transforming the landscape of quantitative market research in UK pharma and healthcare. By harnessing the wealth of information from NHS records, patient registries, claims data, and digital health sources, quant researchers can generate more relevant, evidence-based insights that align with clinical realities and payer expectations. The Growing Importance of RWD […]
Evolving Quantitative Techniques in UK Pharma Research
The UK pharmaceutical and healthcare market research sector has long been at the forefront of quantitative research. As the industry becomes increasingly data-driven, researchers must adapt to evolving methodologies that deliver deeper, more actionable insights. For experienced quant researchers, staying ahead means mastering advanced techniques while aligning with the UK’s unique healthcare and regulatory environment. […]
Future Outlook: Where Pharma & Healthcare Market Research is Headed in the USA
The US pharmaceutical and healthcare market is evolving rapidly, driven by technological advancements, patient-centric care, and regulatory shifts. As we look ahead, market research will play an increasingly pivotal role in guiding strategic decisions, optimising patient outcomes, and maintaining competitive advantage. AI and Advanced Analytics Lead the Way Artificial intelligence (AI), machine learning, […]
The Talent Gap in US Pharma & Healthcare Insights
The United States pharmaceutical and healthcare sectors are at the forefront of global innovation, but a growing talent gap in market research, analytics, and strategic consulting poses a significant challenge. Companies must address this gap to continue driving innovation, delivering value, and making data-driven decisions. Rising Demand for Specialist Roles As the US […]
Strategic Consulting in US Pharma: Driving Competitive Advantage
The US pharmaceutical industry is one of the most innovative and competitive markets in the world. With complex regulations, diverse payer systems, and an evolving healthcare landscape, strategic consulting has become a critical tool for pharma companies seeking to optimise performance, access markets efficiently, and maintain a competitive edge. Navigating Market Access and Payer […]
Healthcare Market Research in the USA: Opportunities and Challenges
The United States healthcare landscape is undergoing significant transformation, driven by technological innovation, regulatory changes, and evolving patient expectations. For businesses operating in the sector, healthcare market research is critical to navigate this complex environment and make informed strategic decisions. Impact of Value-Based Care Models The shift from fee-for-service to value-based care is […]
The State of Pharma & Healthcare Market Research in the USA (2025 Outlook)
The pharmaceutical industry in the United States continues to lead the global market in innovation, with research institutions, biotech firms, and major pharma companies driving advances in drug development, patient care, and healthcare delivery. As we move through 2025, the landscape of pharma & healthcare market research is evolving rapidly, shaped by technological advancements, patient-centric […]